Literature DB >> 20881050

Constraints on HIV-1 diversity from protein structure.

Jeongmin Woo1, David L Robertson, Simon C Lovell.   

Abstract

The high rate of HIV-1 evolution contributes to immune escape, enables the virus to escape drug therapy, and may underlie the difficulty of producing an effective vaccine. Identifying constraints on HIV evolution is therefore of prime importance. To investigate this problem, we examined the relationships between sequence diversity, selection, and protein structure. We found that while there was an increase in sequence diversity over time, this variation had a tendency to be limited to specific structural regions. When individual sites were analyzed, there was, in contrast, substantial and widespread evolutionary constraint over gag and env. This constraint was present even in the highly variable envelope proteins. The evolutionary significance of an individual site is indicated by the change in selection pressure along the time course: increasing entropy indicates that the site is evolving predominantly in a more "clock"-like manner, low entropy values with no increase indicate a high degree of constraint, and high entropy values indicate a lack of constraint. Few sites display high degrees of turnover. Mapping these sites onto the three-dimensional protein structure, we found a significant difference between evolutionary rates for regions buried in the core of the protein and those on the surface. This constraint did not change over the time period analyzed and was not subtype dependent, as similar results were found for subtypes B and C. This link between sequence and structure not only demonstrates the limits of recent HIV-1 evolution but also highlights the origins of evolutionary constraint on viral change.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881050      PMCID: PMC3004343          DOI: 10.1128/JVI.00702-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Distinguishing structural and functional restraints in evolution in order to identify interaction sites.

Authors:  Vijayalakshmi Chelliah; Lan Chen; Tom L Blundell; Simon C Lovell
Journal:  J Mol Biol       Date:  2004-10-01       Impact factor: 5.469

2.  Assessment of protein models with three-dimensional profiles.

Authors:  R Lüthy; J U Bowie; D Eisenberg
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

3.  Prospects for an AIDS vaccine.

Authors:  Ronald C Desrosiers
Journal:  Nat Med       Date:  2004-03       Impact factor: 53.440

4.  Is the evolution of insulin Darwinian or due to selectively neutral mutation?

Authors:  T L Blundell; S P Wood
Journal:  Nature       Date:  1975-09-18       Impact factor: 49.962

5.  Environment-specific amino acid substitution tables: tertiary templates and prediction of protein folds.

Authors:  J Overington; D Donnelly; M S Johnson; A Sali; T L Blundell
Journal:  Protein Sci       Date:  1992-02       Impact factor: 6.725

6.  Tertiary structural constraints on protein evolutionary diversity: templates, key residues and structure prediction.

Authors:  J Overington; M S Johnson; A Sali; T L Blundell
Journal:  Proc Biol Sci       Date:  1990-08-22       Impact factor: 5.349

7.  Solvent-accessible surfaces of proteins and nucleic acids.

Authors:  M L Connolly
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

8.  Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.

Authors:  Todd M Allen; Marcus Altfeld; Xu G Yu; Kristin M O'Sullivan; Mathias Lichterfeld; Sylvie Le Gall; Mina John; Bianca R Mothe; Paul K Lee; Elizabeth T Kalife; Daniel E Cohen; Kenneth A Freedberg; Daryld A Strick; Mary N Johnston; Alessandro Sette; Eric S Rosenberg; Simon A Mallal; Philip J R Goulder; Christian Brander; Bruce D Walker
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes.

Authors:  Marc Choisy; Christopher H Woelk; Jean-François Guégan; David L Robertson
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  X-ray structures of the hexameric building block of the HIV capsid.

Authors:  Owen Pornillos; Barbie K Ganser-Pornillos; Brian N Kelly; Yuanzi Hua; Frank G Whitby; C David Stout; Wesley I Sundquist; Christopher P Hill; Mark Yeager
Journal:  Cell       Date:  2009-06-11       Impact factor: 41.582

View more
  17 in total

Review 1.  Neutralizing antibodies and control of HIV: moves and countermoves.

Authors:  Ann J Hessell; Nancy L Haigwood
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

Review 2.  Collective Infectious Units in Viruses.

Authors:  Rafael Sanjuán
Journal:  Trends Microbiol       Date:  2017-03-03       Impact factor: 17.079

3.  Uneven genetic robustness of HIV-1 integrase.

Authors:  Suzannah J Rihn; Joseph Hughes; Sam J Wilson; Paul D Bieniasz
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

4.  New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention and Cure.

Authors:  Hui Li; Shuyi Wang; Fang-Hua Lee; Ryan S Roark; Alex I Murphy; Jessica Smith; Chengyan Zhao; Juliette Rando; Neha Chohan; Yu Ding; Eunlim Kim; Emily Lindemuth; Katharine J Bar; Ivona Pandrea; Cristian Apetrei; Brandon F Keele; Jeffrey D Lifson; Mark G Lewis; Thomas N Denny; Barton F Haynes; Beatrice H Hahn; George M Shaw
Journal:  J Virol       Date:  2021-03-03       Impact factor: 5.103

5.  HIV-1 envelope accessible surface and polarity: clade, blood, and brain.

Authors:  Gopichandran Sowmya; Gunasagaran Shamini; Sathyanarayanan Anita; Meena Sakharkar; Venkat Mathura; Hector Rodriguez; Andrew J Levine; Elyse Singer; Deborah Commins; Charurut Somboonwit; John T Sinnott; Harcharan S Sidhu; Ganapathy Rajaseger; Peter Natesan Pushparaj; Pandajarasamme Kangueane; Paul Shapshak
Journal:  Bioinformation       Date:  2011-03-22

6.  Intra- and inter-clade cross-reactivity by HIV-1 Gag specific T-cells reveals exclusive and commonly targeted regions: implications for current vaccine trials.

Authors:  Lycias Zembe; Wendy A Burgers; Heather B Jaspan; Linda-Gail Bekker; Helba Bredell; Gwynneth Stevens; Jill Gilmour; Josephine H Cox; Patricia Fast; Peter Hayes; Eftyhia Vardas; Carolyn Williamson; Clive M Gray
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

7.  Differential trends in the codon usage patterns in HIV-1 genes.

Authors:  Aridaman Pandit; Somdatta Sinha
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

8.  Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints.

Authors:  Joke Snoeck; Jacques Fellay; István Bartha; Daniel C Douek; Amalio Telenti
Journal:  Retrovirology       Date:  2011-11-01       Impact factor: 4.602

9.  Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth.

Authors:  Ryan S Roark; Hui Li; Wilton B Williams; Hema Chug; Rosemarie D Mason; Jason Gorman; Shuyi Wang; Fang-Hua Lee; Juliette Rando; Mattia Bonsignori; Kwan-Ki Hwang; Kevin O Saunders; Kevin Wiehe; M Anthony Moody; Peter T Hraber; Kshitij Wagh; Elena E Giorgi; Ronnie M Russell; Frederic Bibollet-Ruche; Weimin Liu; Jesse Connell; Andrew G Smith; Julia DeVoto; Alexander I Murphy; Jessica Smith; Wenge Ding; Chengyan Zhao; Neha Chohan; Maho Okumura; Christina Rosario; Yu Ding; Emily Lindemuth; Anya M Bauer; Katharine J Bar; David Ambrozak; Cara W Chao; Gwo-Yu Chuang; Hui Geng; Bob C Lin; Mark K Louder; Richard Nguyen; Baoshan Zhang; Mark G Lewis; Donald D Raymond; Nicole A Doria-Rose; Chaim A Schramm; Daniel C Douek; Mario Roederer; Thomas B Kepler; Garnett Kelsoe; John R Mascola; Peter D Kwong; Bette T Korber; Stephen C Harrison; Barton F Haynes; Beatrice H Hahn; George M Shaw
Journal:  Science       Date:  2020-11-19       Impact factor: 47.728

10.  Immune activation promotes evolutionary conservation of T-cell epitopes in HIV-1.

Authors:  Rafael Sanjuán; Miguel R Nebot; Joan B Peris; José Alcamí
Journal:  PLoS Biol       Date:  2013-04-02       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.